Skip to main content
. 2015 May 18;2015:163960. doi: 10.1155/2015/163960

Table 2.

The outcomes of RBTM and RATM treatment regimens.

RBTM group (n = 63) RATM group (n = 61) P value
Eradication rate
 Intention-to-treat 92.1% (58/63) 90.2% (55/61) 0.71
 Per-protocol 93.3% (56/60) 89.3% (50/56) 0.44
Compliance 96.8% (61/63) 96.7% (59/61) 0.97
Adverse events 22.2% (14/63) 42.6% (26/61) 0.02